Target intelligence / Profile preview

Actin filament (F-actin)

Target
F-actin
Molecular classification
Other (cytoskeletal filament/protein polymer)
01

Overview

An actin filament (F-actin) is a helical polymer composed of polymerized globular actin (G-actin) subunits that forms a major component of the eukaryotic cytoskeleton[1][3][5]. These filaments are highly dynamic and polar, with distinguishable "barbed" (plus) and "pointed" (minus) ends, and are essential for providing structural support, cell movement, cytokinesis, and, in muscle, facilitating contraction through interactions with myosin[1][3][4][5][9]. Actin filaments can assemble into various higher-order structures in association with numerous actin-binding proteins, and their regulated polymerization and depolymerization are critical for a range of cellular processes including cell shape modulation, intracellular transport, and cellular signaling[1][7][9]. In muscle tissue, actin filaments are known as "thin filaments," which slide against myosin to produce contraction[5][9]. Actin filament dysregulation or mutation is implicated in diseases such as cancer, cardiovascular disorders, some neurodegenerative syndromes, and infection[9]. Certain small molecules and toxins can bind F-actin to either inhibit its polymerization or stabilize filaments, some of which are tools in research or proposed as drug leads, but no clinically approved drugs selectively target actin filaments due to the high risk of severe systemic toxicity[2][3][4].

Other names
Filamentous actinF-actinMicrofilamentActin microfilamentThin filament
02

Mechanism of action

Actin polymerization inhibition, Actin filament stabilization, Actin filament depolymerization

03

Biological functions

Cell motilityCytoskeletal supportMuscle contractionCytokinesisCell shape maintenanceIntracellular transport
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseInfectionOther
05

Safety considerations

Disrupting actin dynamics may cause cytotoxicity, impaired cell motility, muscle dysfunction, and broad cellular toxicity
06

Interacting drugs

Cytochalasin D

3 more in the full profile.

07

Biomarkers

Actin (serum biomarker for tissue injury)F-actin antibodies (in autoimmune hepatitis)

Beyond the preview

Go deeper on Actin filament (F-actin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin filament (F-actin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call